These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32673038)

  • 1. Utility of the Pain Medication Questionnaire to predict aberrant urine drug tests: Results from a longitudinal cohort study.
    Morasco BJ; Iacocca MO; Lovejoy TI; Dobscha SK; Deyo RA; Cavese JA; Hyde S; Yarborough BJH
    Psychol Serv; 2021 Aug; 18(3):319-327. PubMed ID: 32673038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinician Response to Aberrant Urine Drug Test Results of Patients Prescribed Opioid Therapy for Chronic Pain.
    Morasco BJ; Krebs EE; Adams MH; Hyde S; Zamudio J; Dobscha SK
    Clin J Pain; 2019 Jan; 35(1):1-6. PubMed ID: 30222612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment changes following aberrant urine drug test results for patients prescribed chronic opioid therapy.
    Morasco BJ; Krebs EE; Cavanagh R; Hyde S; Crain A; Dobscha SK
    J Opioid Manag; 2015; 11(1):45-51. PubMed ID: 25750164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified.
    Wyse JJ; Morasco BJ; Dobscha SK; Demidenko MI; Meath THA; Lovejoy TI
    J Opioid Manag; 2018; 14(4):295-303. PubMed ID: 30234926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain.
    Setnik B; Roland CL; Pixton GC; Sommerville KW
    Postgrad Med; 2017 Jan; 129(1):5-11. PubMed ID: 27782769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do Urine Drug Tests Reveal Substance Misuse Among Patients Prescribed Opioids for Chronic Pain?
    Larochelle MR; Cruz R; Kosakowski S; Gourlay DL; Alford DP; Xuan Z; Krebs EE; Yan S; Lasser KE; Samet JH; Liebschutz JM
    J Gen Intern Med; 2022 Aug; 37(10):2365-2372. PubMed ID: 34405344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates of opiate misuse based on aberrant urine drug tests for patients on chronic opiate therapy in a safety-net, academic primary care clinic.
    Bakhai S; Thilagar B; Reynolds JL; Leonard KE
    J Opioid Manag; 2018; 14(1):23-33. PubMed ID: 29508893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic opioid therapy urine drug testing in primary care: prevalence and predictors of aberrant results.
    Turner JA; Saunders K; Shortreed SM; LeResche L; Riddell K; Rapp SE; Von Korff M
    J Gen Intern Med; 2014 Dec; 29(12):1663-71. PubMed ID: 25217208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic opioid therapy risk reduction initiative: impact on urine drug testing rates and results.
    Turner JA; Saunders K; Shortreed SM; Rapp SE; Thielke S; LeResche L; Riddell KM; Von Korff M
    J Gen Intern Med; 2014 Feb; 29(2):305-11. PubMed ID: 24142119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk for prescription opioid misuse among patients with a history of substance use disorder.
    Morasco BJ; Turk DC; Donovan DM; Dobscha SK
    Drug Alcohol Depend; 2013 Jan; 127(1-3):193-9. PubMed ID: 22818513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Provider Misinterpretation, Documentation, and Follow-Up of Definitive Urine Drug Testing Results.
    Chua I; Petrides AK; Schiff GD; Ransohoff JR; Kantartjis M; Streid J; Demetriou CA; Melanson SEF
    J Gen Intern Med; 2020 Jan; 35(1):283-290. PubMed ID: 31713040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate of Fentanyl Positivity Among Urine Drug Test Results Positive for Cocaine or Methamphetamine.
    LaRue L; Twillman RK; Dawson E; Whitley P; Frasco MA; Huskey A; Guevara MG
    JAMA Netw Open; 2019 Apr; 2(4):e192851. PubMed ID: 31026029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of urine drug testing for patients with chronic pain: Results from a national cohort of U.S. veterans.
    Morasco BJ; Peters D; Krebs EE; Kovas AE; Hart K; Dobscha SK
    Subst Abus; 2016; 37(1):82-7. PubMed ID: 26516794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine Drug Testing among Opioid-Naïve and Long-Term Opioid Nevada Medicaid Beneficiaries.
    Friedman S; Patel K; Liu Y; Hartzell S; Keller MS
    Subst Use Misuse; 2020; 55(14):2314-2320. PubMed ID: 32835582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An opioid screening instrument: long-term evaluation of the utility of the Pain Medication Questionnaire.
    Holmes CP; Gatchel RJ; Adams LL; Stowell AW; Hatten A; Noe C; Lou L
    Pain Pract; 2006 Jun; 6(2):74-88. PubMed ID: 17309714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinician Ordering and Management Patterns of Urine Toxicology Results at a Cancer Center.
    Yusufov M; Melanson SEF; Kang P; Kematick B; Schiff GD; Chua IS
    J Pain Symptom Manage; 2024 Jul; 68(1):e36-e45. PubMed ID: 38599533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine Drug Test Results Among Adolescents and Young Adults in an Outpatient Office-Based Opioid Treatment Program.
    Ramey OL; Bonny AE; Silva Almodóvar A; Nahata MC
    J Adolesc Health; 2023 Jul; 73(1):141-147. PubMed ID: 37031090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine drug testing in chronic pain.
    Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J
    Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors.
    Gupta A; Patton C; Diskina D; Cheatle M
    Pain Physician; 2011; 14(4):383-9. PubMed ID: 21785482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of the predictive validity of the Pain Medication Questionnaire with a heterogeneous group of patients with chronic pain.
    Dowling LS; Gatchel RJ; Adams LL; Stowell AW; Bernstein D
    J Opioid Manag; 2007; 3(5):257-66. PubMed ID: 18181380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.